No abstract

No abstract

In most cases, the death of neurons in certain parts of the brain is the defining feature of a condition that is classified as neurodegenerative. There have been studies conducted on both conventional and innovative drugs, however the results have shown that they only offer symptomatic advantages and come with a number of undesirable side effects. The finding of more potent compounds that can stop the pathophysiology of these diseases will be seen as a miracle in the present day. There is a wide variety of synthetic compounds accessible; nevertheless, these drugs may also create a broad range of additional health issues. As a consequence of this, scientists are looking to plants and other natural sources for the development of new medicines. In the practise of conventional medicine, it has been discovered that certain plants possess healing powers. The use of phytochemicals, which are produced from medicinal plants, may eventually replace the need for synthetic molecules. Numerous phytochemicals have been shown to be effective in the treatment of a wide range of diseases. This article discusses the potential therapeutic applications of plant-derived alkaloids for a number of neurodegenerative disorders (NDDs), including Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), epilepsy, schizophrenia, and stroke. There are many different types of alkaloids that can be found in the plant kingdom. Some of these alkaloids include isoquinoline, indole, pyrroloindole, oxindole, piperidine, pyridine, aporphine, vinca, -carboline, methylxanthene, lycopodium, and erythrine byproducts. Alkaloids have a beneficial effect on the pathophysiology of these diseases because of their ability to act as muscarinic and adenosine receptor agonists, anti-oxidants, anti-amyloid and MAO inhibitors, acetylcholinestrase and butyrylcholinesterase inhibitors, an inhibitor of synuclein aggregation, dopaminergic and nicotine agonists, and NMDA antagonists.

No abstract

This article provides a concise summary of the recent developments that have been achieved in our comprehension of the asymmetric addition processes that are catalysed by native Cinchona alkaloids and their derivatives. This class of reactions includes cycloadditions, 1,4-adds, direct nucleophilic additions across carbon–oxygen or carbon–nitrogen double bonds, and direct nucleophilic additions across carbon–oxygen double bonds. Because of their capacity to catalyse the addition of a wide variety of functional groups to C9, many Cinchona alkaloids have been utilised in these processes as catalysts. These functional groups include amino, alkoxy, hydroxyl, amido, urea, and thiourea, among others. The importance of mechanical variables is emphasised in many different contexts. Additionally, the utilisation of adducts in future synthesis is sometimes broken down into its component steps. Ocimum basilicum was discovered to be mostly consisted of estragol (> 35.71 percent), (E)-ocimene (> 1.47 percent), trans-bergamotene (> 0.83 percent), a-cadinol (> 0.41 percent), eucalyptol (> 0.25 percent), and -caryophyllene (> 0.07 percent), whereas Ocimum sanctum is primarily composed of eucaly There is a greater concentration of chemical components in the leaves of Ocimum basilicum and Ocimum sanctum than there is in the actual inflorescence or flowers of the plant. The genetic distance between the two species was analysed in order to better understand the interspecies relationship, and the results showed that it was 2.86. The small difference in genetic makeup that exists between Ocimum basilicum and Ocimum sanctum is evidence that these two species are related to one another and share similar traits.